SCHEMBL14528580

SCHEMBL14528580

B/C(C=C)=C/C=C\C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19192554 0.74
SCHEMBL18789081 0.74
SCHEMBL23026401 0.72
SCHEMBL18780120 0.71 ALDH1A1 (0.32)
SCHEMBL27570570 0.71
SCHEMBL18569616 0.71
SCHEMBL5439770 0.69
SCHEMBL5439775 0.69
SCHEMBL23652660 0.69
SCHEMBL18684039 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127333-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed
US-10859578-B2 Fluorescent methods and materials for directed biomarker signal amplification SKIGEN, INC. (US) 2020-12-08 US disclosed
EP-2279291-B1 COFERONS AND METHODS OF MAKING AND USING THEM UNIV CORNELL (US) 2019-07-03 EP disclosed
US-20190033317-A1 Fluorescent Methods and Materials for Directed Biomarker Signal Amplification SIRIGEN, INC. 2019-01-31 US disclosed